We report two cases of macular infarction as a presenting sign of systemic lupus erythematosus (SLE).
S ystemic lupus erythematosus (SLE) is an autoimmune disease characterized by the deposition of autoantibody immune complexes throughout the body. It is more commonly seen in women and blacks, with an incidence of 2 to 5 cases per 100,000 population per year in the United States. 1 Ocular complications have been found in up to one third of patients with SLE. 2, 3 Previous articles have described such anterior segment findings as keratoconjunctivitis sicca, 4 conjunctivitis, episcleritis, scleritis, 5, 6 interstitial keratitis, and iridocyclitis. 7 SLE involvement of the posterior segment includes cottonwool spots, intraretinal hemorrhages, 5 retinal artery and/or vein occlusion, 8 central serous chorioretinopathy, 9 optic neuritis, 10 and papilledema secondary to increased intracranial pressure. 11 There have been few angiographically documented cases of macular nonperfusion in the setting of SLE (Table 1) . [12] [13] [14] [15] [16] [17] In most patients with angiographic documentation, macular ischemia was the presenting sign of SLE. 12, 13, 17 We report two cases of macular ischemia as the initial finding in SLE and review the literature. The collected cases support the view that macular ischemia can occur early in the course of SLE and that the visual prognosis tends to be poor.
Case Reports

Case 1
A 29-year-old Latina woman presented to the Manhattan Eye, Ear & Throat Hospital Emergency Department with a 2-week history of photopsias and progressive visual loss bilaterally. The patient also had arthralgias and headaches for 6 months and noted Supported in part by The Macula Foundation. Reprint requests: Emmett T. Cunningham, Jr, MD, West Coast Retina Medical Group, Inc., 185 Berry Street, Lobby 5, Suite 130, San Francisco, CA 94107-1739; e-mail: emmett_cunningham@ yahoo.com intermittent rashes and fever over the last 2 years. Her medical history was significant for systemic hypertension.
At examination, the patient was afebrile, and blood pressure was 160/100 mmHg. Visual acuity was counting fingers in each eye. The pupils were reactive with no afferent papillary defect. Intraocular pressure and results of anterior segment examination were normal bilaterally. Posterior segment examination revealed trace vitreous cells, numerous sclerotic vessels, multiple cotton-wool spots, and scattered intraretinal hemorrhages in each eye (Fig. 1, A and B). Fluorescein angiography revealed extensive macular nonperfusion bilaterally (Fig. 1, C and D) .
The patient was admitted to the hospital for evaluation. Laboratory testing revealed an erythrocyte sedimentation rate of 100 mm/h and an antinuclear antibody titer of 1:1,280 in a speckled pattern. Anticardiolipin antibody titers were negative. Magnetic resonance imaging of the brain without gadolinium revealed multiple punctate hyperintensities within the supratentorial white matter, consistent with cerebral vasculitis. The Rheumatology Department was consulted and made the diagnosis of SLE with both retinal and cerebral vasculitis. Solumedrol treatment was started intravenously, and the patient reported resolution of headache. Her disease was ultimately controlled with azathioprine therapy. Vision remained poor, however.
Case 2
A 31-year-old Indian Asian woman presented with loss of vision in the left eye for 10 days. She also reported fever, anorexia, and weight CF, counting fingers.
loss over the last 3 months. Other systemic complaints included arthralgias, malar skin eruption, oral ulcers, dysacusis, and poliosis. Best-corrected visual acuity was 20/200 in the right eye and 20/20 in the left eye. Results of external and anterior segment examinations were unremarkable. Posterior segment examination revealed trace vitreous cells and scattered sclerotic vessels with multiple cotton-wool spots and scattered intraretinal hemorrhages in each eye (Fig. 2, A and B) . Fluorescein angiography revealed extensive macular nonperfusion bilaterally (Fig. 2, C and D) .
Systemic evaluation revealed mucosal pallor and ulcerations and cyanotic extremities. The leukocyte count and hemoglobin level were both low at 4,000/mm 3 and 4 mg%, respectively. The erythrocyte sedimentation rate was elevated at 104 mm/h, and the antinuclear antibody titer was positive (above the 1:320 cutoff for a positive test), confirming the diagnosis of SLE. Anticardiolipin antibody titers were negative.
Vision loss progressed to 10/200 in the right eye and 20/200 in the left eye over the next 2 months in spite of treatment with high-dose oral corticosteroids (60 mg/d). The oral corticosteroid dose was tapered, and systemic treatment with methotrexate (15 mg once a week) was started. She subsequently developed seizures and was referred for a neurologic workup.
Discussion
Macular infarction is an uncommon complication of SLE. However, with the addition of our patients, six of the nine patients had this finding as the initial manifestation of their disease (Table 1) . Gold et al 17 described a woman with bilateral nonperfusion of the macular capillary bed who presented with vision loss and was subsequently diagnosed with SLE. Sellami et al 13 described two patients who presented with Purtscher-like retinopathy unrelated to trauma and were eventually diagnosed with SLE. Cooper et al 12 described a patient presenting with macular ischemia and a facial rash who ultimately developed SLE. The diagnosis of SLE was already established in only three of the cases of macular ischemia listed in Table 1 . 14 -16 Furthermore, in only one of the nine patients with SLE-related macular ischemia did pulse corticosteroid treatment improve vision. 12 Papadaki et al 18 described two patients with lupus retinal vasculitis and decreased vision, one of whom appeared to have widespread retinal capillary dropout on the published angiogram (although the researchers themselves did not refer to the findings as macular ischemia or infarction). Of note, both patients failed to respond to treatment with systemic corticosteroids and cyclophosphamide, but their conditions did improve after multiple rounds of plasmapheresis.
Beyond SLE, the differential diagnosis of macular ischemia is broad (Table 2 ). Gass 19 was the first to describe various disorders that could lead to macular ischemia, including retinal artery and vein occlusions, systemic hypertension, diabetes mellitus, retinal telangiectasis, and radiation retinopathy. Since then, additional reports have implicated inflammatory diseases such as Behçet disease 20 -22 and sarcoidosis, 20 infectious causes such as human immunodeficiency virus infection, 23, 24 thrombotic states such as sickle-cell disease 25, 26 and thrombotic thrombocytopenic purpura, 27 and further iatrogenic causes such as aminoglycoside toxicity 28, 29 and transpupillary thermotherapy. 30 Although overall systemic disease severity appears to be the greatest risk factor for the development of lupus-related retinopathy, the presence of anticardiolipin antibodies also appears to confer added risk for retinal vascular occlusion in patients with SLE. 31 Moreover, recent reports have described elevated anticardiolipin antibody levels with retinal artery and vein occlusions and in the absence of SLE or conventional risk factors, [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] and it has been suggested that the presence of such autoantibodies can, irrespective of a diagnosis of SLE, lead to retinal vessel occlusion. 42 Although, to our knowledge, no histopathological studies have been reported on the eyes of patients with elevated anticardiolipin antibody levels in the absence of SLE, Nag and Wadhwa 43, 44 examined the eyes of patients with SLE and suggested that occlusion results from immune complex-induced occlusion 19 Retinal vein occlusion 19, 45 Malignant hypertension 19, 46 Diabetes mellitus 19, 47 Retinal telangiectasis 19 Radiation retinopathy 19, 48 Carotid artery occlusion 19 Posterior uveitis 19 Behç et disease [20] [21] [22] Sarcoidosis 20 Idiopathic retinal vasculitis 20 Acquired immunodeficiency syndrome 23, 24 Thrombotic thrombocytopenic purpura 27 Transpupillary thermotherapy 30 Incontinentia pigmenti 49 Talc retinopathy 50, 51 Sickle-cell retinopathy 25, 26 Aminoglycoside toxicity, intravitreal and topical 28, 29 Purtscher retinopathy 52 of small retinal vessels, which manifests clinically as cotton-wool spots.
In summary, we have reviewed the literature and reported two additional cases of macular ischemia presenting as the initial manifestation of SLE with no evidence of elevated anticardiolipin antibody titers. Although macular ischemia is an uncommon complication of SLE, when present it is often the initial sign of the disease, and visual prognosis tends to be poor, despite the use of high-dose systemic corticosteroids and noncorticosteroid immunosuppressive agents.
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